POST-ACUTE COVID-19
Clinical trials for POST-ACUTE COVID-19 explained in plain language.
Never miss a new study
Get alerted when new POST-ACUTE COVID-19 trials appear
Sign up with your email to follow new studies for POST-ACUTE COVID-19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could an antiviral pill ease long COVID?
Disease control OngoingThis study tests whether the antiviral drug ensitrelvir can help people with Long COVID by clearing leftover virus from the body. About 40 adults with persistent symptoms will receive either the drug or a placebo. The main goal is to see if the drug improves physical health and r…
Matched conditions: POST-ACUTE COVID-19
Phase: PHASE2 • Sponsor: Timothy Henrich • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Could an antibody finally treat long COVID?
Disease control OngoingThis study tests whether a single dose of the monoclonal antibody AER002 can safely improve physical health in adults with Long COVID. The idea is that lingering virus or spike protein may cause ongoing symptoms, and the antibody might clear it. 36 participants will receive eithe…
Matched conditions: POST-ACUTE COVID-19
Phase: PHASE2 • Sponsor: Michael Peluso, MD • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC